IPPRA / Grant Monitor

2026-09-06
3129Open opportunities
23IPPRA ≥ 60
0Not yet characterized
580Awaiting detail
2026-09-05Last fetch
Lens
Deadline
Score
Funds
Topic
Category
IPPRA fit Opportunity Topics Ceiling Posted Closes Days
24 Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) PAR-25-371 · National Institutes of Health · basic research biomedical clinical public health social services 2025-01-13 2026-11-18 73
22 Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) PAR-25-095 · National Institutes of Health · basic research biomedical clinical ai data science public health $350,000 2024-11-18 2026-11-06 61
12 Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed) PAR-25-255 · National Institutes of Health · basic research biomedical clinical ai data science public health 2024-11-15 2026-11-05 60
12 Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) PAR-25-370 · National Institutes of Health · basic research biomedical clinical public health arts humanities culture $50,000 2025-01-13 2026-11-16 71
12 Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) PAR-25-369 · National Institutes of Health · basic research biomedical clinical public health education workforce 2025-01-13 2026-11-18 73
12 Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) PAR-25-256 · National Institutes of Health · basic research biomedical clinical ai data science public health 2024-11-15 2027-01-07 123
8 Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) PAR-25-069 · National Institutes of Health · basic research biomedical clinical public health ai data science 2024-11-18 2027-01-07 123
8 Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed) PAR-25-070 · National Institutes of Health · basic research biomedical clinical public health 2024-11-18 2027-01-07 123
5 National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) PAR-25-081 · National Institutes of Health · basic research biomedical clinical public health computing communications $499,999 2024-11-12 2027-01-07 123
5 NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed) PAR-24-269 · National Institutes of Health · basic research biomedical clinical mental behavioral health ai data science 2024-08-13 2027-02-11 158

10 OF 10 ROWS